Tag Archives: mutual-fund

5 Best-Rated T. Rowe Price Mutual Funds For High Returns

T. Rowe Price is a renowned publicly owned investment management firm, headquartered in Baltimore, Maryland. The company was founded in 1937 by Thomas Rowe Price, Jr. The company manages assets worth $725.5 billion (as of September 30, 2015). It prides itself in having more than 5,000 employees across the world. The company offers a full range of investment planning and guidance tools. It also offers mutual funds, subadvisory services, retirement plans and separate account management for individual clients. Below, we share with you 5 top-rated T. Rowe Price mutual funds. Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and we expect the fund to outperform its peers in the future. T. Rowe Price Financial Services (MUTF: PRISX ) seeks both capital growth and current income. The majority of its assets are invested in companies in the financial services sector. PRISX may also purchase securities of companies with significant linkages to the sector. The T. Rowe Price Financial Services fund returned 7.9% in the last one year. As of September 2015, this T. Rowe Price mutual fund held 87 issues, with 4.41% of its total assets invested in Citigroup Inc. T. Rowe Price Mid-Cap Growth (MUTF: RPMGX ) maintains a diversified portfolio by investing a large chunk of its assets in companies having market capitalizations similar to those listed in the S&P MidCap 400 Index or the Russell Midcap Growth Index. RPMGX invests in companies having above-average growth potential. Though RPMGX focuses on acquiring common stocks of domestic companies, it may also invest in companies located outside the U.S. The T. Rowe Price Mid-Cap Growth fund has returned 12.6% over the past one year. RPMGX has an expense ratio of 0.77% as compared to a category average of 1.28%. T. Rowe Price Global Technology (MUTF: PRGTX ) invests the majority of its assets in companies which expect to derive a large proportion of their revenues from the development and application of technology. PRGTX generally invests in at least 5 countries and allocates 25% of its investments to stocks of companies located outside the U.S. The T. Rowe Price Global Technology fund has returned 21.8% over the past one year. Joshua K. Spencer is the fund manager and has managed PRGTX since 2012. T. Rowe Price International Discovery (MUTF: PRIDX ) seeks capital growth over the long term. PRIDX invests a large share of its assets in foreign companies and purchases stocks issued from both mature and emerging markets. PRIDX focuses on investing in small and mid-cap companies. The T. Rowe Price International Discovery fund has returned 8.9% over the past one year. PRIDX has an expense ratio of 1.21% as compared to a category average of 1.53%. T. Rowe Price Health Sciences (MUTF: PRHSX ) invests a major portion of its assets in common stocks of companies whose primary operations are related to health sciences. PRHSX focuses on investing in large and mid-cap firms. PRHSX may also invest in non-U.S. securities. The T. Rowe Price Health Sciences fund returned 16.7% over the last one-year period. Taymour R. Tamaddon is the fund manager and has managed PRHSX since 2013. Original Post

Best-Performing No Load Mutual Funds In Q3 Of 2015

It is always best to get the most out of one’s invested capital. One way of doing it is by cutting down on the expenses that investors have to bear for owning or selling mutual funds. So, buying funds that carry no sales is the best option. Sales loads are one-time fees that investors pay either at the time of purchase or when units are redeemed. The importance of sales load was all the more felt in the third quarter, when the key benchmarks posted their worst quarterly performance in four years. Just 17% of the mutual funds managed to finish in the green in the third quarter. This was a slump from 41% in the second quarter, which was again a sharp fall from 87% of the funds ending in the positive territory in the first quarter. Separately, a JPMorgan equity strategy note revealed that 67% of mutual funds underperformed their benchmarks in the third quarter. Around 34% of the funds underperformed their peers by a minimum of 250 basis points. The Dow, S&P 500 and Nasdaq declined 7.6%, 7% and 7.4%, respectively. In such torrid times, the list of best-gaining mutual funds for the quarter is dominated by no load mutual funds. Robust gains were restricted to Bear Market funds in the third quarter, and were followed by modest gains in other categories. However, the no load funds were unfazed, as they had enough representation in most of the categories. Among the top 100 performers in the third quarter, 85 funds carried no sales load. The best-performing fund in the quarter, ProFunds UltraShort Latin America Fund Inv (MUTF: UFPIX ), gained 67.1%, and needless to mention, it is a no load mutual fund. Comparative Study: No Load Funds’ Q3 Show Out of the 15,129 no load funds we studied, 2, 316 funds posted positive returns in the third quarter. The average gain for these funds came at 1.6%. Among the top 100 performers, the average gain was a significant 12.9%. This is a quite a feat for the top 100 funds that almost reached the top-performing category Bear Market’s quarterly gain of 13.1%. It was followed by Long Government and Long-Term Bond categories’ gains of respectively 4.3% and 1.7%. The disparity in gains among the categories is indicative of how tough a quarter it was for funds. The average gain for the top 100 no load funds in the second quarter was 8.9%. The average gain of the top 100 no load funds also outperformed the average 4.1% gain of the top 100 funds that carry sales load. The load-adjusted return for these funds would again bring down the 4.1% average return. Moreover, the best-performing no-load fund’s quarterly gain of 67.1% far outpaced the top-performing fund with sales load, Rydex Inverse Emerging Markets 2X Strategy Fund A (MUTF: RYWWX ), which gained 43%. RYWWX carries a maximum front-end sales load of 4.75%. (Note: These numbers include same mutual funds of varied classes) Top 15 No-Load Mutual Fund Performers Below we present the top 15 no load mutual funds with the best returns in 3Q of 2015: Fund Name Objective Description Q3 Total Return Q3% Rank vs. Obj. YTD Total Return % Yield Expense Ratio Minimum Initial Investment ($) Beta vs. S&P 500 Rydex Invr Emerging Mrkts 2X Str H Foreign 43.03 1 37.47 0 1.73 2500 -0.27 Rydex Inverse Russell 2000 2x Strat H Growth 24.5 1 8.81 0 1.82 2500 -2.4 Rydex Inverse Russell 2000 Strat H Growth 11.99 1 5.09 0 1.7 2500 -1.2 Rydex Inverse Dow 2X H Agg Growth 11.6 2 8.14 0 1.84 2500 -2.16 Rydex Inverse S&P 500 2x Str H Growth 10.24 1 5.08 0 1.77 2500 -2.02 Gabelli Comstock Capital Value AAA Flexible 10.05 1 3.3 0 2.42 1000 -0.96 Federated Prudent Bear C Growth 7.93 1 0.49 0 2.51 1500 -0.73 Rydex Inverse Mid Cap Strategy H Growth 7.86 1 2.42 0 1.65 2500 -0.97 ATAC Inflation Rotation Investor AssetAlloc 7.33 1 11.69 0.32 1.74 2500 -0.03 Arrow Managed Future Trend C AssetAlloc 7.22 1 4.09 0 2.91 5000 0.19 Rydex Govt Long Bond 1.2x Str Inv Government 6.8 1 -2.16 1.08 0.95 2500 -0.1 GAMCO Mathers Fund AAA Flexible 6.12 2 1.71 0 4.6 1000 -0.53 Fidelity Spartan Long Treas Inv Government 5.49 1 — 2.55 0.2 2500 -0.06 Goldman Sachs Managed Futures C AssetAlloc 5.46 1 12.27 0 2.26 1000 -0.07 Vanguard Long-Term Treasury Inv Government 5.44 2 0.08 2.63 0.2 3000 -0.04 Note: The list excludes the same funds with different classes, and institutional funds have been excluded. Funds having minimum initial investment above $5000 have been excluded. Q3 % Rank vs. Objective* equals the percentage the fund falls among its peers. Here, 1 being the best and 99 being the worst. The top half of this list of 15 best-performing no load mutual funds is dominated by funds that employ the short-selling or inverse strategy. Top performer, Rydex Inverse Emerging Markets 2X Strategy Fund A, seeks a return that is 200% of the inverse daily performance of the BNY Mellon Emerging Markets 50 ADR Index. RYWYX, however, now carries a Zacks Mutual Fund Rank #4 (Sell) . Similarly, the next four funds in the list, Rydex Inverse Russell 2000 2x Strat H, Rydex Inverse Russell 2000 Strat H, and Rydex Inverse Dow 2X H, Rydex Inverse S&P 500 2x Str H seek inverse returns. Funds from the Government Bond category also had a decent representation in this list of best gainers. Remember, this category was the second-best gainer among fund categories in the third quarter, according to Morningstar data. Rydex Government Long Bond 1.2x Strategy Fund Inv (MUTF: RYGBX ), Fidelity Spartan Long Term Trust Bond Index Fund Inv (MUTF: FLBIX ) and Vanguard Long Term Treasury Fund Inv (MUTF: VUSTX ) posted gains of 6.8%, 5.5% and 5.4%, respectively. Each of these three funds carries a Zacks Mutual Fund Rank #1 (Strong Buy) . Separately, ATAC Inflation Rotation Fund Inv (MUTF: ATACX ) and GAMCO Mathers Fund No Load (MUTF: MATRX ), which posted respective gains of 7.3% and 6.1%, carry a Zacks Mutual Fund Rank #3 (Hold) each. The best-performing RYWYX’s gain of over 43% was substantially higher than the second-quarter top scorer Matthews China Dividend Fund Inv ‘s (MUTF: MCDFX ) gain of 14.7%. However, while we have nine funds this time with sub 10% total return, only six had ended below 10% in the second quarter’s top performer list. Also, the lowest gain in the third quarter list of 5.4% compares unfavorably with the second quarter’s 15th-ranked Emerald Banking and Finance Fund Inv ‘s (MUTF: FFBFX ) gain of 8.2%. Original Post

Investors May Be Doing The Wrong Thing (Again)

Summary In this article, I delve a little deeper into my recommended Model Stock Portfolio funds to try to get a fresh perspective that cannot be found elsewhere. The snapshot that emerges is intended to further help result-seeking investors judge what might be the best choices going forward within a group of already highly recommended funds. Investors often invest heavily in funds whose holdings are tilted toward previously strongly performing but overvalued stocks, rather than from those with a better chance of showing future strength. It should go without saying that no single or even multiple selection criteria hold the key to which funds you should hold on to and with what emphasis in your portfolio. However, in my Newsletters down through more than 15 years, I have tried to make the case that, while there are numerous good funds (or ETFs) to choose from, the best long-term results are more likely when, even within a list of highly rated funds, one focuses on those composed of stocks that are relatively more undervalued vs. those made up of stocks which have already been “discovered,” and therefore, likely have seen most of their potential run-up in prices already. Expressed a little differently, some funds may have achieved their recent success by their emphasis on holding a preponderance of already recognized “winning” stocks and stock categories and continuing to ride those winners. A simple example is funds that hold a relatively large proportion of what has proven to be an amazing stock, Apple (NASDAQ: AAPL ). The same may be said for funds that have a relatively high proportion of recently high-performing technology stocks as a group. Two such funds I have consistently recommended are the Vanguard Growth Index Fund (MUTF: VIGRX ) (or its equivalent ETF) and Fidelity Contra (MUTF: FCNTX ). The former currently holds 7.5% of the fund in Apple and 26% of the fund in Technology companies. The latter holds about 3.8% in Apple and 29% in technology stocks. Given the excellent performance over recent years of these fund components, the heavy weighting has given a boost to both these funds (and many other similarly categorized Large Growth funds), and been a contributing factor as to why these two funds have beaten the S&P 500 Index on average over many years. But another even more striking example can be cited: funds investing heavily in Health Care, such as PRIMECAP Odyssey Growth (MUTF: POGRX ), Vanguard Health Care (MUTF: VGHCX ) or Vanguard Health Care ETF (NYSEARCA: VHT ). Not surprisingly, the latter two highly narrow-focused funds have nearly all their investments in this one sector, a stock subclass that has on average returned over 20% annualized over the last five years. While, unfortunately, I have never included any of these funds in my Model Stock Portfolios, I have recommended at least one fund with greater than a 20% weighting in Health Care currently, namely T. Rowe Price Value Fund (MUTF: TRVLX ), This fund’s track record against its Large Cap Value category peers has been admirable over the last five years. Beyond this, though, is where things get very murky. As an investor, do you want to stick with funds that invest heavily in stocks and categories that have shown a lot of past momentum in the hopes that this outstanding performance will continue? Or, do you want, perhaps, to trim down your holdings of such funds, and instead for at least the next few years, favor funds more heavily invested in stocks and categories that may show even greater potential for success, namely those choosing the majority of their investments in potentially less overvalued segments of the market? Unfortunately, there is no clear-cut answer to this dilemma. Therefore, it is probably wisest to own funds weighted in both, that is, funds that invest heavily in stocks with strong current momentum, and, those that can potentially become better choices when the former momentum-driven stocks start to lose altitude. Unfortunately too, one of investors’ biggest downfalls happen when the winds of change periodically cause a big shift in the performance of previously winning stocks, categories, and the funds investing heavily in them. While we haven’t seen any such sort of massive shift going back perhaps to the 2007-09 financial crisis, or even before, we know that many investors tend to suffer when outsized bets on previous winners turn into outsized losses. While no one can say with any degree of certainty if and when the next reversal of fortune may befall the current crop of big winners in stocks, what follows is an analysis of which of my recently recommended funds are holding stocks perhaps overloaded with past winning, but now likely overvalued, categories of stocks. And, on the other side of the coin, can I identify which of my recommendations are more oriented toward current ownership in categories that seem to be less likely to underperform, when the next big shift in stock market winners and losers takes hold and impacts fund results for possibly years into the future? A Closer Look at My Model Stock Portfolio Funds In the first list of funds below, I analyze broadly diversified domestic stock funds recommended (or recently so) in my Model Stock Portfolio to examine the above issue. I also include some additional funds that I hold in my own personal investment portfolio. Funds more broadly classified as international stock or narrow-focused sector funds, however, are not included. For each listed fund, I have scored the fund on the extent to which it is currently (based on latest data available) invested in either what appear to be fairly priced categories of stocks, or on the other hand, seemingly overvalued categories, based on my own proprietary research. See the note at the bottom of the list for the meaning of scores. Each fund is listed in a descending order of score, starting with those least likely to be overvalued . Those with greater potential for coming out on top over the next 3 to 5 years, assuming my scoring method proves valid, are listed closer to the top; those that may be strong winners recently, but having a greater potential for underperformance when their current chosen and often overvalued stock selections lose momentum, are found further down the list. Note: If one compares the results shown in the list with the allocations shown in my Oct. ’15 Model Stock Portfolio , the results may not completely agree with the recommendations there because the listing below is based on different data. It should come as no surprise that all of the funds below, because they are diversified mixes of stocks, will have a moderate proportion of their investments in overpriced stock categories, given what we have previously labeled as an overall overvalued market. Therefore, inclusion in this list below in no way ensures that most or all of these funds will prove to be great investments over the next few years. But relatively speaking, we chose these funds, that is, those that are managed, aiming to beat market indices, or at least do well against their similarly classified peers. However, it is very possible, too, that perhaps some of the best investments for the next few years instead may turn out to be in funds that are invested internationally, as generally speaking, these fund categories seem to be relatively more undervalued than U.S. domestic funds are at the present time. Best Model Stock Portfolio Choices (from most highly rated* to less highly rated) Fund Name (Symbol) Score 3 Yr. Return (thru 10-27) (ann.) Category 1. T. Rowe Price Equity Income (MUTF: PRFDX ) 76% 10.6% Large Value 2. Vanguard US Value (MUTF: VUVLX ) 74% 16.5% Large Value 3. Fidelity Large Cap Stock (MUTF: FLCSX ) (tie) 70% 15.5% Large Blend 3. Vanguard Equity-Income (MUTF: VEIPX ) (tie) 70% 13.9% Large Value 3. Vanguard Small Cap Index (MUTF: NAESX ) (tie) 70% 14.7% Small Blend 6. Vanguard Extended Market Idx (MUTF: VEXMX ) 68% 15.0% Mid-Cap Blend 7. T. Rowe Price Value (tie) 65% 16.4% Large Value 7. Vanguard Mid Cap Index Adm (MUTF: VIMAX ) (tie) 65% 17.1% Mid-Cap Blend 9. Vanguard Small Cap Growth Index (MUTF: VISGX ) 64% 13.6% Small Growth 10. Vanguard Windsor II (MUTF: VWNFX ) 63% 13.4% Large Value 11. Vanguard 500 Index (MUTF: VFINX ) 62% 15.8% Large Blend 12. Fidelity Contrafund (tie) 58% 17.1% Large Growth 12. Vanguard Growth Index (tie) 58% 16.9% Large Growth 14. Fidelity Low-Priced Stock (MUTF: FLPSX ) 55% 15.2% Mid-Cap Value 15. AMG Yacktman Service (MUTF: YACKX ) 39% 11.7% Large Blend *Note: Top rating possible is 100%; lowest possible rating is 0%. A score of 70%, for example, means that 70% of the stocks in the fund are judged to be within a class of stocks that is fairly valued while 30% are within a category that my research indicates is overvalued. Of course, funds in the above list that are managed (that is, not index funds) will have the option of switching out of overvalued categories if it is decided to make such a switch. Index funds must stick to their mandated benchmark and typically will not change their composition unless the underlying index changes. Funds with the Most Investor Assets As a basis of comparison with the above funds and to see alternative funds chosen by investors that have currently attracted the most investor assets, it is also informative to look at similarly derived scores of the most popular funds using the same criteria to rate each in terms of my measure of fair vs. overvalued stock portfolio composition. (The first list also includes some of the biggest funds; it also includes a few that mirror some of the most important indices such as the S&P 500, so we won’t show funds that are identical or nearly so to those there. And, I again exclude international and sector funds.) Biggest Funds by Assets (from most highly rated* to less highly rated) Fund Name (Symbol) Score 3 Yr. Return (thru 10-27) (ann.) Category 1. Dodge & Cox Stock (MUTF: DODGX ) 71% 16.1% Large Value 2. Vanguard Value ETF (NYSEARCA: VTV ) 69% 15.0% Large Value 3. American Funds Washington Mutual A (MUTF: AWSHX ) 67% 14.4% Large Value 4. American Funds Invmt Co of Amer A (MUTF: AIVSX ) (tie) 64% 15.0% Large Blend 4. Vanguard Total Stock Mkt Idx Adm (MUTF: VTSAX ) (tie) 64% 15.8% Large Blend 6. American Funds Fundamental Inv A (MUTF: ANCFX ) (tie) 61% 15.3% Large Blend 6. American Funds AMCAP A (MUTF: AMCPX ) (tie) 61% 17.0% Large Growth 8. American Funds Growth Fund of Amer A (MUTF: AGTHX ) 54% 16.8% Large Growth 9. Fidelity Growth Company (MUTF: FDGRX ) 50% 19.6% Large Growth 10. T. Rowe Price Growth Stock (MUTF: PRGFX ) 48% 19.9% Large Growth *Note: See the Note under the first table. If you look carefully over these two lists, you will notice that the majority of funds with the highest, that is, best forward-looking scores, are categorized as Large Value funds. And, almost equally noticeable, most of the funds with a large percentage of already “discovered” stock categories, especially in the second list, are Large Growth funds. What this suggests is that the best opportunities for investors for the next several years would appear to lie in US stock funds that are classified as Large Value. Many Large Growth funds, if this analysis is valid, are likely to perform less strongly than Large Value funds because investors may have already realized most of the performance benefits of this category and are more likely to find both a greater degree of safety in Large Value funds when market conditions are no longer as bright, and a greater degree of return potential due to their less overvalued composition. While there is no way to know for sure how long the current “momentum bias” will continue, as it very well may, investors might always want to keep in mind that over long periods of time, the best way to make money in stocks is to establish and maintain your positions when prices are relatively low. It seems apparent, however, that looking at the second list featuring those funds investors have the most money invested in, they seem to be opting for many funds, including unmanaged index funds, with a relatively greater degree of already “stretched” types of stocks.